NDC product
Guaifenesin Extended-Release 1200 mg
NDC 53041-234 · Guardian Drug Company
Key facts
| Product NDC | 53041-234 |
|---|---|
| Proprietary name | Guaifenesin Extended-Release 1200 mg |
| Nonproprietary name | Guaifenesin |
| Substances | GUAIFENESIN |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Labeler | Guardian Drug Company |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA209215 |
| Marketing start | Mar 1, 2018 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: